• Issues
    • Current Issue
    • Special Issues
  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • A Day in the Life
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • COVID-19 News
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma & Plasma Cell Disorders
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
    • Red Blood Cell & Iron Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Search
  • ASH Home
  • About ASH Clinical News
  • Authors
  • Advertising
  • Subscribe
  • Contact Us
  • eNewsletters
  • Cookie Settings
  • LOG IN
Welcome! Log into your account
Forgot your password?
Recover your password
ASH Clinical News
  • Issues
    • AllCurrent IssueSpecial Issues

      Mid-January 2021 Annual Meeting Edition

      January 2021 Volume 7 Issue 1

      December 2020, Volume 6, Issue 15

      November 2020 Bonus ASH Annual Meeting Preview Edition (Volume 6, Issue…

  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • A Day in the Life
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • COVID-19 News
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma & Plasma Cell Disorders
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
    • Red Blood Cell & Iron Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
    Anne T. Neff, MD

    Anne T. Neff, MD

    Department of Hematology/Medical Oncology at the Cleveland Clinic in Cleveland, Ohio
    • For orthopedic surgery, is tranexamic acid standard for pre- and peri-operative anticoagulation? Sunday, November 1st, 2015

      This month, Anne T. Neff, MD, answers a question about tranexamic acid for pre- and peri-operative anticoagulation.

    admin
    Advertisement

    Current Issue

    Mid-January 2021 Annual Meeting Edition

    Friday, January 15, 2021
    This issue features highlights from the 2020 ASH Annual Meeting, a look at doctor-patient gifting customs around the world, and more.

    Block title

    CRISPR Gene Editing May Offer Curative Potential for Sickle Cell Disease

    Wednesday, January 20, 2021

    Editor’s Corner: A Period Piece

    Tuesday, January 19, 2021

    Bethany T. Samuelson Bannow, MD

    Tuesday, January 19, 2021

    Loss of STK11/LKB1 Drives Progression to Leukemia in Myeloproliferative Neoplasms

    Friday, January 15, 2021

    FLAG-IDA Plus Venetoclax Associated With High Response Rates in Acute Myeloid Leukemia

    Friday, January 15, 2021
    Recent Posts
    • CRISPR Gene Editing May Offer Curative Potential for Sickle Cell Disease
    • Editor’s Corner: A Period Piece
    • Loss of STK11/LKB1 Drives Progression to Leukemia in Myeloproliferative Neoplasms
    • FLAG-IDA Plus Venetoclax Associated With High Response Rates in Acute Myeloid Leukemia

    Meeting Coverage

    MLL Associated With Worse Post-Transplant Outcomes Than Other Cytogenetic Factors

    Friday, May 1, 2020

    Study Examines Trends in Real-World Treatment Sequencing Patterns for CLL/SLL

    Sunday, March 1, 2020

    Editor's Corner

    Editor’s Corner: A Period Piece

    Tuesday, January 19, 2021

    There’s No Crime Like the Presents

    Friday, January 15, 2021
    2021 L Street NW, Suite 900, Washington, DC 20036
    Phone 202-776-0544 | Fax 202-776-0545
    • ASH Home
    • Research
    • Education
    • Advocacy
    • Meetings
    • Publications
    • ASH Store
    Copyright © 2020 by American Society of Hematology

    Contact Us | Terms of Service | Privacy Policy